BioSpace News Archive

Authorization brings more instruments on line, enables workflow flexibility and simplifies methods to increase throughput and allow more labs to run tests

Sri Kosaraju will transition from his role as President to join nonprofit focused on COVID-19 testing; will remain advisor to CEO Adam Elsesser

Anika Therapeutics, Inc., a global, integrated joint preservation and regenerative therapies company, announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will present at the 2020 UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020 at 8:20 a.m. ET.

Kriya is focused on rationally designed gene therapies for severe chronic conditions affecting millions of patients

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month period ended March 31, 2020 (“Q1-2020). Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (“IFRS”). Q1-2020 Highlights Refinancing transactions provide $18 million of new capital to suppor

Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, reported financial results for the first quarter ended March 31, 2020, and provided a corporate update.

Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, presented advances from its “off-the-shelf” or allogeneic platform at the American Society for Gene and Cell Therapy Annual meeting which kicked off in virtual format.

Enzo Biochem, Inc. a leading biosciences and diagnostics company, announced the recent issuance of U.S. Patent No. 10,626,170 entitled Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor.

Ovid Therapeutics Inc. announced that Amit Rakhit, M.D., MBA, President and Chief Medical Officer, will participate in a fireside chat at the 2020 RBC Capital Markets Virtual Global Healthcare Conference on Tuesday, May 19, at 1:20 p.m. ET.

Homology Medicines, Inc., a genetic medicines company, announced the presentation of data at the American Society of Gene & Cell Therapy 23rd Annual Meeting.